Healthcare Business News
 

Abbott to buy Galapagos arthritis-drug rights for up to $1.35 billion


By Bloomberg.com
Posted: February 29, 2012 - 1:45 pm ET
Tags:

Abbott Laboratories agreed to pay Galapagos as much as $1.35 billion for rights to an experimental rheumatoid arthritis drug that would compete with a Pfizer pill.

READ MORE »


Advertisement | View Media Kit

 


What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.